Dear Doctor, My mother, who is in her fifties, was diagnosed with HIV a year ago and started taking ARVs immediately. ;Her viral load is suppressed and she has been well but of late she likes to spend ...

Sarcopenia influences toxicity and survival in non-small cell lung cancer, and sarcopenia assessment can be factored into ...

A new study suggests there may be an easy way to predict which women are most at risk – low creatinine-to-cystatin C ratios.

The International Conference on Frailty and Sarcopenia Research (ICFSR) is a leading annual scientific event dedicated to accelerating the development of clinical trials for frail older adults.

The Company’s recently initiated Phase 2b clinical trial will further evaluate isomyosamine as a treatment for chronic inflammation associated with muscle loss (frailty or sarcopenia ...

A Phase 2b clinical trial is currently underway to evaluate isomyosamine as a treatment for chronic inflammation associated with muscle loss (frailty or sarcopenia) in patients who have undergone ...

TNF Pharmaceuticals (TNFA) announced that data from the Phase 2a clinical trial of its oral TNF-alpha inhibitor drug candidate isomyosamine was ...

inhibitor drug candidate isomyosamine was presented last week in a podium session at the peer-reviewed 15th International Conference on Frailty and Sarcopenia Research (ICFSR) held March 12-14 ...

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...